Altmedical

Altmed (Alternative Medical Enterprises) is a research-oriented medical cannabis company that focuses on the development and commercialization of pharmaceutical-grade cannabinoid products. Founded in 2014 by pharmaceutical industry veterans, the company applies rigorous scientific standards to the cultivation, extraction, and formulation of its therapies. Its flagship brand, MÜV, features a diverse portfolio of delivery methods, including patented transdermal patches, metered-dose inhalers, and various topical and oral formulations. Altmed was acquired by Verano Holdings in 2021, merging its operations to create one of the largest multi-state operators in the United States.